These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Inhibitory effects of ketotifen on eotaxin-dependent activation of eosinophils: consequences for allergic eye diseases. Woerly G, Loiseau S, Loyens M, Schoch C, Capron M. Allergy; 2003 May; 58(5):397-406. PubMed ID: 12752326 [Abstract] [Full Text] [Related]
7. Differentiation stages of eosinophils characterized by hyaluronic acid binding via CD44 and responsiveness to stimuli. Watanabe Y, Hashizume M, Kataoka S, Hamaguchi E, Morimoto N, Tsuru S, Katoh S, Miyake K, Matsushima K, Tominaga M, Kurashige T, Fujimoto S, Kincade PW, Tominaga A. DNA Cell Biol; 2001 Apr; 20(4):189-202. PubMed ID: 11403716 [Abstract] [Full Text] [Related]
8. The CCR3 receptor is involved in eosinophil differentiation and is up-regulated by Th2 cytokines in CD34+ progenitor cells. Lamkhioued B, Abdelilah SG, Hamid Q, Mansour N, Delespesse G, Renzi PM. J Immunol; 2003 Jan 01; 170(1):537-47. PubMed ID: 12496441 [Abstract] [Full Text] [Related]
12. Novel co-operation between eotaxin and substance-P in inducing eosinophil-derived neurotoxin release. El-Shazly A, Ishikawa T. Mediators Inflamm; 1999 Jan 01; 8(3):177-9. PubMed ID: 10704057 [Abstract] [Full Text] [Related]
13. Human umbilical vein endothelial cells support interleukin-3- and interleukin-5-induced eosinophil differentiation from cord blood CD34+ cells. Ochiai K, Omura M, Mochizuki A, Ito M, Tomioka H. Int Arch Allergy Immunol; 1999 Jan 01; 120 Suppl 1():2-6. PubMed ID: 10529593 [Abstract] [Full Text] [Related]
14. Increased response of blood eosinophils to various chemotactic agents in quiescent Crohn disease. Denis MA, Louis R, Malaise M, Belaiche J, Louis E. Scand J Gastroenterol; 2001 Feb 01; 36(2):190-5. PubMed ID: 11252412 [Abstract] [Full Text] [Related]
15. Eosinophil differentiation of human umbilical cord mononuclear cells and prolonged survival of mature eosinophils by murine EL-4 thymoma cell conditioned medium. Ten RM, Butterfield JH, Kita H, Weiler DA, Fischkoff S, Ishizaka T, Sanderson CJ, Gleich GJ. Cytokine; 1991 Jul 01; 3(4):350-9. PubMed ID: 1873484 [Abstract] [Full Text] [Related]
16. Growth and differentiation of eosinophils from human peripheral blood CD 34+ cells. Shalit M. Allerg Immunol (Paris); 1997 Jan 01; 29(1):7-10. PubMed ID: 9025988 [Abstract] [Full Text] [Related]
17. Effects of rapamycin, cyclosporin A, and dexamethasone on interleukin 5-induced eosinophil degranulation and prolonged survival. Meng Q, Ying S, Corrigan CJ, Wakelin M, Assoufi B, Moqbel R, Kay AB. Allergy; 1997 Nov 01; 52(11):1095-101. PubMed ID: 9404561 [Abstract] [Full Text] [Related]
18. Expressions of Eotaxin-3, Interleukin-5, and Eosinophil-Derived Neurotoxin in Chronic Subdural Hematoma Fluids. Kawaguchi R, Osuka K, Aoyama M, Miyachi S, Takayasu M. J Neurotrauma; 2018 Oct 01; 35(19):2242-2249. PubMed ID: 29764285 [Abstract] [Full Text] [Related]
19. Pimecrolimus reduces eosinophil activation associated with calcium mobilization. Plager DA, Henke SA, Matsuwaki Y, Madaan A, Squillace DL, Dierkhising RA, Kita H. Int Arch Allergy Immunol; 2009 Oct 01; 149(2):119-26. PubMed ID: 19127068 [Abstract] [Full Text] [Related]